UnitedHealth Group Incorporated navigated a turbulent 2025 with management changes, mispriced costs, and a surging medical cost ratio, but revenue growth remained robust. We expect 2026 EPS guidance in the high teens, signaling a double-digit rebound off 2025's $16.25–$16.50 floor, with confirmation of inflection imminent at the upcoming earnings. Dividend growth and a 2.8% yield provide income while awaiting margin recovery; buybacks are paused but likely to resume as cash flow improves.

Klarna CEO Sebastian Siemiatkowski says Americans are being ripped off by high credit card rates and that rate caps have been effective in Europe. Siemiatkowski discusses President Trump's call for a one-year 10% cap on credit card interest rates https://bloom.bg/4qWCzHY

Edgewise Therapeutics, Inc. (EWTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Beam Therapeutics jumps 22% after outlining 2026 pipeline goals, including accelerated approval plans for BEAM-302 and a potential risto-cel BLA filing.

Dell has told its employees to expect a companywide systems overhaul in May. Top exec Jeff Clarke told workers it would be the "biggest transformation" in its 42-year history.

Alphabet (GOOGL) still has room to run, says Ali Mogharabi. When it comes to its new partnership with Apple (AAPL), Ali expects Alphabet will hold a treasure chest of data which its Gemini AI models can largely benefit from.

US stock market falls across all indices as tech stocks fade. Dow drops on JPMorgan 3% slide while Nasdaq-100 turns negative despite Intel, AMD rallies.

MCLEAN, Va.--(BUSINESS WIRE)--Hilton Worldwide Holdings Inc. (NYSE: HLT) will report fourth quarter and full year 2025 financial results before the stock market opens on Wednesday, Feb. 11, 2026, followed by a conference call at 9 a.m. EST. Christopher J. Nassetta, president & chief executive officer, Hilton, and Kevin Jacobs, executive vice president & chief financial officer, Hilton, will discuss the company's performance and lead a question-and-answer session. Participants may listen.

Calavo Growers Inc (NASDAQ: CVGW) will release earnings for the fourth quarter after the closing bell on Wednesday, Jan. 14.

A fresh look at global semiconductor supply chains is reshaping analyst views as hyperscaler demand accelerates and memory constraints tighten across the industry.

Meta plans to cut roles in its metaverse unit as it pivots to AI-devices. Nancy Tengler, CEO and CIO of Laffer Tengler Investments, who has been bearish on Meta, discusses why she supports a move away from the metaverse with Caroline Hyde and Ed Ludlow on "Bloomberg Tech.

Putnam Focused Large Cap Value ETF targets high-conviction, large-cap U.S. value stocks with a concentrated portfolio. PVAL's net expense ratio of 0.55% is high compared to other similar products. Historically, PVAL has delivered very strong performance relative to the S&P 500 and value oriented strategies with reasonable levels of volatility.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Vaalco Energy (EGY) offers compelling value at current levels, trading at a low 2.55x EV/EBITDA and $20K per flowing barrel. EGY's near-term upside is driven by resumed drilling in Gabon, seismic activity in Cote d'Ivoire, and exploration progress in Equatorial Guinea. Risks include dependence on Gabon drilling success, oil price volatility, and a high dividend payout ratio nearing 91%.

MILWAUKEE, Jan. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating Sun Country (NASDAQ: SNCY) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Allegiant Travel. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.

Philadelphia, Pennsylvania--(Newsfile Corp. - January 13, 2026) - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) as a securities fraud class action has reached a settlement. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

Rising geopolitical tensions pushed oil prices to multi-week highs.

Nebius Group N.V. stock may have put in a bottom. There's room for NBIS stock to run to over $150. Execution and bottleneck risks threaten the bull thesis.

DAL tops Q4 estimates despite high labor costs and unveils major 787-10 fleet upgrade to boost global expansion.

Gold.com (GOLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.